Name | N-(2-Methyl-2-propanyl)-1-(1-{5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl}-4-piperidinyl)-1H-imidazole-5-carboxamide |
---|---|
Synonyms |
N-(2-Methyl-2-propanyl)-1-(1-{5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl}-4-piperidinyl)-1H-imidazole-5-carboxamide
1H-Imidazole-5-carboxamide, N-(1,1-dimethylethyl)-1-[1-[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]-4-piperidinyl]- WNK463 |
Description | WNK463 is an orally bioavailable pan-WNK-kinase inhibitor with IC50s of 5, 1, 6, and 9 nM for WNK1, WNK 2, WNK 3, and WNK 4, respectively. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C21H24F3N7O2 |
Molecular Weight | 463.456 |
Exact Mass | 463.194366 |
LogP | 2.01 |
Index of Refraction | 1.631 |
Storage condition | -20℃ |